SPATA20 and hilar cholangiocarcinoma: Intense PGAM-1, HSPD1, PDIA3 and SSP411 cytoplasmic immunoreactivity was observed in both hilar cholangiocarcinoma (Figure 5) and intrahepatic cholangiocarcinoma (Figure S2).